483 Daniel Claassen, M.D. Sep 2015

483 Daniel Claassen, M.D. Sep 2015

Donna Gallien FDA, Abby Mozeke-Baker FDA$119.00 - Available Now

FDA investigators audited the Daniel Claassen, M.D. - Nashville, TN, United States facility and issued inspectional observations (via FDA 483) on 17 Sep 2015.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Sep 2015
  • Location: Nashville, United States
  • FEI: 3011703002
Add To Cart